Health information to help you understand symptoms. It isn't a diagnosis.
Check symptoms

Research deep dives

Nutrition during leukemia treatment and recovery: what helps, what interferes

Last reviewed November 16, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.

This is the part of the subject with the most marketing and the least evidence, so it is worth being blunt at the start: nothing you eat treats leukemia, and some things you might take can make the treatment work less well.

Within those limits, nutrition genuinely matters. Weight loss and muscle loss during treatment make everything else harder.

Related pages: Leukemia (blood cancer)

The bottom line

What we know
  • Treatment under an oncology team is what treats leukemia. Nutrition supports it and does not replace it.
  • Adequate protein and energy help preserve muscle during treatment.
  • Some supplements interfere with chemotherapy and targeted drugs, including folic acid with methotrexate and St John's wort with many drugs.
  • The restrictive neutropenic diet has been tested and does not reduce infections more than ordinary food-safety practice.
What is still open
  • Whether any specific supplement improves outcomes in leukemia. So far none has been shown to.
  • How much high-dose antioxidants during treatment actually blunt its effect in humans, as opposed to in laboratory models.

The story, step by step

  1. 1. The ground rule ()
  2. 2. Folate ()
  3. 3. Protein and weight ()
  4. 4. Food safety ()
  5. 5. The supplement list ()
What the evidence labels mean
GuidelineAn official recommendation from an expert group after weighing all the evidence.
Review of many studiesCombines the results of many studies (a systematic review or meta-analysis).
Randomized trialPeople were randomly given a treatment or a comparison, the best way to test cause and effect.
Large observational studyFollows many people over time. Shows strong links, but not always cause and effect.
Small or early studyA small study, case series, or first results. Needs to be confirmed.
Lab or animal studyDone in cells or animals. May not apply to people.
Part 1 of 5

Tell the team everything you take

Review of many studies

What happens

The most useful thing on this page is a conversation, not a nutrient.

What the research shows

  • Supplements, herbs and teas are drugs with poor labelling. They are metabolized by the same liver enzymes as cancer medicines.
  • St John's wort speeds the breakdown of many drugs, including several leukemia treatments, and can push blood levels below the range that works.
  • Grapefruit and Seville orange do the opposite for some drugs, raising levels into the toxic range. This matters for several kinase inhibitors.
  • High-dose antioxidant supplements during treatment are discouraged, because some treatments work partly by oxidative damage and the concern is that blunting that could blunt the treatment.
  • Pharmacists on the oncology team will check interactions on request, and this is one of the best uses of their time.

Why it matters

This is not a caution about exotic products. Ordinary supermarket supplements are the ones that cause these problems.

What's still uncertain

  • Interaction evidence is stronger for some combinations than others, which is why the advice is to ask rather than to follow a blanket rule.

Read more

Next: Folate

Part 2 of 5

The one that can genuinely go wrong

Review of many studies

What happens

This deserves its own section because the instinct to take a B vitamin is so common and here it can be harmful.

What the research shows

  • Methotrexate, used in ALL treatment, works by blocking folate metabolism in dividing cells.
  • Taking folic acid supplements during that treatment can work directly against the drug.
  • Folate rescue is given deliberately, as a prescribed medicine called leucovorin, at times chosen by the oncology team. That is not the same as taking a supplement.
  • Vitamin B12 deficiency should be tested rather than assumed, and treated on medical advice.
  • The rule is simple: during treatment, take folate only if your oncology team prescribes it.

Why it matters

This is the clearest example of a supplement that is healthy in general life and counterproductive during a specific treatment.

What's still uncertain

  • Dietary folate from ordinary food is not the same as high-dose supplements; ask your team what applies to you.

Read more

Next: Protein and weight

Part 3 of 5

The thing that actually helps

Review of many studies

What happens

Losing weight and muscle during treatment is associated with worse tolerance of treatment and more complications.

What the research shows

  • Oncology dietitians typically aim for a higher protein intake than usual during treatment, often in the region of 1.2 to 1.5 grams per kilogram of body weight per day, individualized to the person.
  • That target is not right for everyone. Kidney disease, liver disease and some treatments change it, which is why it should be set by a dietitian rather than taken from a table.
  • Eating is often the hard part: nausea, mouth sores, taste changes and appetite loss are all common.
  • Practical approaches, small frequent meals, cold foods when smells are difficult, and oral nutrition supplements, matter more than the precise nutrient mix.
  • Glutamine has been studied for chemotherapy-related mouth sores with mixed and largely unconvincing results, and is not routinely recommended.

Why it matters

Ask for a referral to an oncology dietitian early rather than when weight has already dropped. They are usually part of the cancer centre and under-used.

What's still uncertain

  • Nutrition trials in cancer are hard to run and most are small, so guidance leans on expert consensus more than on large trials.

Read more

Next: Food safety

Part 4 of 5

What the evidence actually supports

Review of many studies

What happens

When neutrophil counts are low, infection risk rises. The traditional response was a restrictive neutropenic diet, and it has been tested.

What the research shows

  • Randomized trials comparing a restrictive neutropenic diet with ordinary food-safety practice found no reduction in infections.
  • Standard food-safety practice is what is recommended now: wash produce, cook meat, poultry, eggs and seafood thoroughly, avoid unpasteurized dairy and juice, separate raw and cooked foods, and keep cold food cold.
  • Avoid raw sprouts, undercooked eggs and raw shellfish, which carry higher risk for anyone immunocompromised.
  • Individual centres still vary in what they advise, so follow your own team's instructions, which may be stricter around transplant.

Why it matters

The useful shift here is from a long list of banned foods to ordinary careful handling, which is easier to follow and works as well.

What's still uncertain

  • Practice around stem cell transplant is more cautious and differs between centres.

Read more

Next: The supplement list

Part 5 of 5

Where the common recommendations stand

Review of many studies

What happens

Several nutrients get recommended specifically for marrow recovery. Here is where each stands.

What the research shows

  • Vitamin D: deficiency is common and worth testing and correcting. Beyond correcting a deficiency, no trial has shown that vitamin D improves leukemia outcomes.
  • Magnesium: some treatments lower it, and low levels are corrected medically. Taking it routinely is not supported, and it can bind other drugs in the gut.
  • Iron: do not supplement without testing. Anemia in leukemia is usually caused by marrow failure, not iron shortage, and people who have had many transfusions can have too much iron rather than too little.
  • Probiotics: generally avoided when counts are very low or around transplant, because live organisms have caused bloodstream infections in immunocompromised people.
  • Prebiotic fibre: plausible and under study, but not established during active treatment.

Why it matters

The pattern across all of these is the same: correct a measured deficiency, and be sceptical of anything offered beyond that.

What's still uncertain

  • Most of these have been studied in general cancer populations rather than in leukemia specifically.

Read more

More plain-language reading

See something wrong or unclear on this page? Suggest a correction. OwieClear is for education only and isn't medical advice.